Planta Med 2005; 71(11): 1036-1039
DOI: 10.1055/s-2005-873123
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Diterpenes Isolated from Croton zambesicus Inhibit KCl-Induced Contraction

Chiara Baccelli1 , Sébastien Block1 , Benoit Van Holle1 , André Schanck2 , David Chapon2 , Bernard Tinant2 , Luc Van Meervelt3 , Nicole Morel4 , Joelle Quetin-Leclercq1
  • 1Laboratoire de Pharmacognosie, Unité d’Analyse Chimique et Physico-Chimique des Médicaments, Université Catholique de Louvain, Bruxelles, Belgium
  • 2Unité CSTR, Département de Chimie, Université Catholique de Louvain, UCL 28.15, Louvain-la-Neuve, Belgium
  • 3Biomolecular Architecture, Chemistry Department, K.U. Leuven, Leuven, Belgium
  • 4Laboratoire de Pharmacologie, Université Catholique de Louvain, UCL 54.10-FARL, Bruxelles, Belgium
Further Information

Chiara Baccelli

Laboratoire de Pharmacognosie

Unité d’Analyse Chimique et Physico-Chimique des Médicaments

Université Catholique de Louvain

UCL 72.30-CHAM

Av. E. Mounier 72

1200 Bruxelles

Belgium

Phone: +32-(0)276-47230

Fax: +32-(0)276-47253

Email: chiara.baccelli@cham.ucl.ac.be

Publication History

Received: October 12, 2004

Accepted: May 30, 2005

Publication Date:
17 October 2005 (online)

Table of Contents #

Abstract

A mixture of two new diterpenes was isolated from a dichloromethane extract of Croton zambesicus: ent-18-hydroxytrachyloban-3β-ol (1) and ent-18-hydroxyisopimara-7,15-diene-3β-ol (2). The two compounds crystallised together and were separated after derivatisation of the pimarane derivative with osmium tetroxide. The structure of 1 was elucidated by 1D- and 2D-NMR analysis and by X-ray diffraction of a crystal containing both compounds while 2 was only identified by crystallographic data. As this plant is widely used in African folk medicine against hypertension, we have analysed the vasorelaxant activity of the isolated molecules. The mixture of the two compounds inhibited the KCl-induced contraction of male Wistar rat aorta (IC50 = 1 μg/mL), while the purified trachylobane (compound 1) and the hydroxylated pimarane showed a lower activity than the mixture.

#

Introduction

Croton zambesicus Muell. Arg. is a plant widely used in African traditional medicine. Phytochemical studies have shown the presence of clerodanes, labdanes and trachylobanes in the stem bark [1], [2]. More recently, trachylobanes (ent-trachyloban-3β-ol, ent-trachyloban-3-one, ent-18-hydroxytrachyloban-3-one) possessing moderate cytotoxic activity on HeLa cells (IC50 = 7.3, 12.2, 9.6 μg/mL, respectively) were isolated from the leaves of C. zambesicus [3], [4].

In the present work, we report the characterisation of two new diterpenes: ent-18-hydroxytrachyloban-3β-ol (1) and ent-18-hydroxyisopimara-7,15-diene-3β-ol (2) isolated from the dichloromethane extract of the C. zambesicus leaves (Fig. [1]).

As the leaves of Croton zambesicus are used in African folk medicine to treat hypertension [5], we tested whether these compounds could behave as Ca++ channel blockers and inhibit KCl-evoked contractions, and evaluated their cytotoxicity.

Zoom Image

Fig. 1 Structures of ent-18-hydroxytrachyloban-3β-ol (1) and 18-hydroxyisopimara-7,15-dien-3β-ol (2).

#

Materials and Methods

#

General experimental procedure

High speed counter-current chromatography was performed on an HSCCC Kromaton III, SEAB. An Omnifit glass column (OM 6427 15 × 750 mm) packed with Lichroprep Si 60 (15 - 25 μM, Merck) was used for MPLC. Analytical TLC was performed on precoated silica gel 60 F254 plates (Merck) and detection was achieved by spraying with sulphuric acid-anisaldehyde, followed by heating 5 min at 105 °C. NMR spectra were recorded on a Bruker Avance 500 spectrometer in CDCl3 with TMS as internal reference. MS analyses were achieved using electronic impact ionisation (EI-MS, 70eV) on a Finnigan TSQ700 triple quadrupole instrument.

#

Plant material

The aerial parts of Croton zambesicus were collected in the Cotonou area (Benin) and identified by Prof. V. Adjakidje (Université d’Abomey-Calawi, Bénin). A voucher has been deposited at the herbarium of Belgian National Botanical Garden at Meise (BR S.P. 848.108).

#

Extraction and isolation

580 g of air-dried powdered leaves were macerated (1800 mL of CH2Cl2 during 48 h) and then extracted by percolation (3200 mL of CH2Cl2 at room temperature) to give 34 g of final extract. 5 g of this extract were fractionated by HSCCC using the two-phase solvent system heptane-acetonitrile-CH2Cl2 (10 : 7:3) in the descending mode with the lower phase as mobile phase, (flow rate: 2 mL/min, rotation: 500 rpm, volume of column: 1000 mL). 8-mL fractions were collected to obtain 21 fractions (F1 - F21).

The most polar fraction (F3, 529 mg, tr between 180 and 240 mL) was purified by MPLC on silica gel 60 Merck® (15 - 25μM) eluted with toluene/EtOAc/HOAc (90 : 2:5), 6 mL/min, giving 7 fractions (F3.1 - F3.7). Fraction 3.7 (267.6 mg, tr between 1858 and 2502 mL) was further purified by MPLC on silica gel 60 (15 - 25μM) eluted with toluene/EtOAc/HOAc (90 : 5:5) (flow rate: 6 mL/min) giving 3 fractions (F3.7.1 - F3.7.3). Fraction 3.7.2 (99 mg, tr between 460 and 880 mL) was finally purified by MPLC on silica gel 60 (15 - 25 μM) eluted with toluene/EtOAc (93 : 7) (flow rate: 6 mL/min) to give 58 mg of a mixture of two compounds (tr between 496 and 676 mL). The eluates were monitored by TLC (SiO2 toluene/EtOAc/MeOH, 80 : 18 : 2, anisaldehyde-sulphuric acid reagent), Rf 1 and 2 : 0.23. They were only separated by capillary GC on a DB-XLB column (J&W Scientific).

Isolation of 1 was only possible after hydroxylation of 2 : 10 mg of the mixture were dissolved in 1 mL of EtOAc/MeOH/H2O (5 : 4:1) with 40 mg of N-methylmorpholine N-oxide and 600 μL of OsO4 (0.1 M solution) at room temperature. The reaction was complete after 24 h.

Preparative TLC on silica gel (2 mm) Merck® without fluorescence indicator, using toluene/EtOAc/acetonitrile (50.20 : 30) as mobile phase allowed us to isolate 5 mg of compound 1 (Rf: 0.46) and 4 mg of hydroxylated pimarane (Rf: 0.08).

#

Cytotoxicity tests

Compounds were tested on HeLa cells as described by Block et al. [3]. The effect was evaluated using the tetrazolium salt MTT (Sigma) colorimetric method based on the cleavage of the reagent by dehydrogenase in viable cells. The relative absorbances were expressed as percent of the control and camptothecin (Sigma) was used as positive control.

#

Measurement of aorta contraction

Male Wistar rats weighing 200 to 300 g were sacrificed by decapitation. The descending thoracic aortas were isolated, cleaned and cut in rings (2 mm). Contractile responses were measured as described by El Bardai et al. [6]. Aortic rings were suspended under a resting tension of 20 mN in 12.5-mL organ baths filled with a physiological solution [composition (mM): NaCl, 122; KCl, 5.9; NaHCO3, 15; MgCl2 1.25; CaCl2, 1.25; glucose, 11] maintained at 37 °C and bubbled with a gas mixture of 95 % of O2 and 5 % CO2.

Preparations were submitted to a basal tension of 20 mN and allowed to equilibrate for 60 min before initiating the experimental procedures. Contractions were induced by changing the physiological solution in the bath to a depolarising solution [100 mM; composition (mM): NaCl, 27; KCl, 100; NaHCO3, 15; MgCl2 1.25; CaCl2, 1.25; glucose, 11].

After washing, the muscles were pre-incubated for 30 min in the presence of the compounds and a second contraction was evoked in the continuous presence of the tested compounds. The amplitude of the contraction induced in the presence of the tested compounds was compared to the response in its absence. Tested compounds were dissolved in DMSO as stock solutions at 10 mg/mL. Due to their low water solubility, the highest concentration that could be realised in the organ bath was 3 μg/mL. Verapamil was dissolved in water.

Data were corrected for the change in contraction measured after aorta incubation with the same concentration of DMSO, which maximally decreased contraction by 5 %.

#

Results and Discussion

Purification of the dichloromethane extract allowed us to isolate a mixture of two diterpenes having the same Rf and Rt values in TLC and HPLC systems and the same molecular formula, C20H32O2.

Compound 1 {[α]D 22: -72° (CH2Cl2, c 0.1)} was isolated from the mixture as a white powder, whose molecular formula, C20H32O2, was established by HR-EI-MS (m/z = 304.2402 [M]+ · calculated for C20H32O2 : 304.2402). Infrared absorptions at 3520 cm-1 provided evidence of hydroxy groups. The presence of a cyclopropane ring was deduced from the 1H-NMR spectrum that showed two signals at δH = 0.57 and 0.82 ppm (H-12 and H-13, respectively), and by the 13C-NMR spectrum that showed signals at δC = 20.5 (C-12), 24.2 (C-13), 22.5 (C-16) ppm. From these observations and comparisons with NMR data from closely related structures [3], [4], [7], [8], [9], [10], we could conclude that compound 1 belongs to the trachylobane series of diterpene. The NMR data are shown in Table [1]. The presence of two hydroxy groups was confirmed by the two signals at δC = 72.1 and 77.1 ppm in the 13C-NMR spectrum.

The primary alcohol was revealed in the 1H-NMR spectrum by the two doublets at 3.69 and 3.39 and the tertiary alcohol by the doublet of doublets at 3.61. These attributions were confirmed by the DEPT spectrum of the molecule. The stereochemistry was established by NOE correlations between H-18 (3.69 and 3.39), H-3 (3.61) and H-5 (0.84). The assignment of the tertiary alcohol at C-3 was confirmed by HMBC correlations between the protons at δH = 1.57 (H-2), 0.87 (Me-19), 3.69 (H-18a), 3.39 (H-18b) and the carbon at δC = 77.1 (C-3). The equatorial position of the hydroxy group at C-3 was deduced by the observation of the coupling constants of the dd at δH = 3.61 (J = 9.5 and 7.0 Hz, H-3) and by NOE correlations between H-3 (3.61) and H-5 (0.84). The full 1H- and 13C-NMR assignments were established with COSY, HMQC and HMBC correlations. All the naturally-occurring trachylobane diterpenes isolated so far belong to the enantio series, NOE correlations between H-5 and H-3, H-19 and H-20, H-17 and H-12, H-9 and H-12 and between H-5 and H-9 and comparison with other ent-trachylobanes confirmed the ent-configuration of compound 1 [3], [7], [8], [9], [10]. Compound 1 was identified as ent-18-hydroxytrachyloban-3β-ol and its structure was confirmed by X-ray crystallographic analysis (Figs. [1] and [2]).

Compound 2 could not be isolated with enough purity to undertake an NMR analysis. Its structure has been elucidated only by X-ray diffraction of a crystal of a mixture of the two compounds.

It has been identified as an ent-isopimarane diterpene: ent-18-hydroxyisopimara-7,15-dien-3β-ol (Fig. [1]). The absolute configuration could not be elucidated because of lack of NMR data but it could be deduced from X-ray diffraction knowing the absolute configuration of 1.

Fig. [2] shows the ORTEP [11] view and atom labelling of ent-18-hydroxytrachyloban-3β-ol and of ent-18-hydroxyisopimara-7,15-dien-3β-ol .

Table 1 NMR data of compound 1 [CDCl3, 500.200 MHz (1H), 125.775 MHz (13C), δ ppm (J in Hz)]
Position 1H 13C HMBC (C→H)
1a 1.52 m 37.12 H-2, H-20
1b 0.86 m
2 1.57 m 26.57
3 3.61 dd
(9.5, 7.0)
77.06 H-1a, H-19
4 - 41.81 H-2, H-18a, H-18b,
H-19
5 0.84 m 49.69 H-18a, H18b, H-19,
H-20
6 1.33 m 20.08
7 1.38 m 38.60 H-15a
8 - 40.49 H-13, H-14a, H-15a,
H15-b
9 1.09 dd
(11.0, 7.3)
53.12 H-14a, H-15a, H15-b,
H-20
10 - 37.89 H-2, H-19
11a 1.87 ddd
(14.7, 11.0, 2.9)
19.70
11b 1.66 ddd
(14.7, 7.3, 2.6)
12 0. 57 ddd
(7.3, 2.9, 2.6)
20.51 H-15a, H-15b, H-17
13 0.82 m 24.21 H-11a, H-14a, H-15b,
H-17
14a 2.04 d (12.0) 33.41 H-15b
14b 1.15 d (12.0)
15a 1.39 d (11.3) 50.33 H-14a, H-17
15b 1.22 d (11.3)
16 - 22.50 H-11b, H-14a, H-15a,
H-15b, H-17
17 1.12 s 20.52 H-15a, H-15b
18a 3.69 d (10.3) 72.10 H-19
18b 3.39 d (10.3)
19 0.87 s 11.26
20 0.98 s 14.98
Zoom Image

Fig. 2 ORTEP view and atom labelling of ent-18-hydroxytrachyloban-3β-ol and 18-hydroxyisopimara-7,15-dien-3β-ol.

#

X-Ray structure analysis

Colourless crystals were obtained by slow evaporation from a dichloromethane solution of the mixture of the 2 compounds. Molecular formula = C20H32O2, M r = 304.46, monoclinic, P21, a = 10.780(1), b = 7.373(1), c = 21.677(2) Å, β = 90.03(1)°, V = 1722.8(2) Å3 , Z = 4, Dx = 1.17 g cm-3, μ = 0.56 mm-1, F(000) = 672 , T = 100 K.

A total of 14 616 reflections were collected using a Bruker CCD detector and Cu-Kα radiation (λ = 1.54178 Å) - 6175 independent reflections (Rint = 0.081). The structure was solved by direct methods with SHELXS-97 [12] and refined by the least square using F2 values and anisotropic thermal parameters for non-hydrogen atoms with SHELXL-97 [12]. The angle β was 90° but the orthorhombic symmetry was not observed. All the H atoms were calculated and included in the refinement with a common isotropic temperature factor. Final R values are: R 0.068 for 4867 observed reflections, R (all data) = 0.082, wR = 0.168, S = 0.99. The data have been registered with the Cambridge Crystallographic Data Centre (CCDC 240 618).

Only four hydrogen bonds are observed in the structure. One of these four H-bonds is intramolecular, it is observed in molecule 1 between the two hydroxy groups forming a six-membered ring. In 2, the CH2-OH group is nearly perpendicular to ring A of the tricyclic skeleton so that this intramolecular H-bond is no longer possible.

The three intermolecular H-bonds lead to an infinite two-dimensional network. It is noteworthy to mention that only one H-bond is observed between the two different entities 1 and 2. It is probably this interaction between the two different molecules 1 and 2 that leads to the observed solid solution. Examples of such solid solutions have been found in steroids [13]. The X-ray structure of vitamin D1 reveals a sandwich-like heterodimer complex of very structurally dissimilar molecules [14].

As Croton zambesicus is used in African traditional medicine to treat hypertension, we investigated the activity of the mixture of 1 and 2, of the isolated ent-18-hydroxytrachyloban-3β-ol and of the hydroxylated pimarane derivative on KCl-induced contraction. Marrubenol, a diterpene with known vasorelaxant activity associated with Ca++-antagonist properties, and verapamil were used as reference compounds [6], [15].

The 1 : 1 mixture of the two compounds [0.3 - 3 μg/mL] did not affect aorta basal tone but inhibited the KCl-induced contraction in a concentration-dependent manner with an IC50 of 1 μg/mL (corresponding to 3.3 μM of diterpenes, both compounds having the same molecular weight: 304.24) while the IC50 values of marrubenol and verapamil were 3.3 and 0.057 μg/mL or 10 and 0.025 μM, respectively [6], [15]. The trachylobane and the hydroxylated pimarane showed a much lower activity than the 1 : 1 mixture which is about 3 times more active than marrubenol (Table [2]). As far as we know, trachylobane diterpenes are poorly known from a pharmacological point of view and no previous study on the vasorelaxant activity of trachylobanes has been reported. On the contrary, some pimaranes are known to possess vasorelaxant activity [16], [17].

In comparison to the weak activity of 1, the higher activity of the mixture could be explained by a synergy between trachylobane and pimarane or, more probably, by a stronger activity of the pimarane component in its original non-hydroxylated form.

Neither the mixture of the two compounds nor compound 1 exhibited cytotoxicity when tested on HeLa cells (IC50 >20 μg/mL).

Table 2 Effects of ent-18-hydroxytrachyloban-3β-ol (1), the hydroxylated derivative of ent-18-hydroxyisopimara-7,15dien-3β-ol and a mixture of 1 and 2 on the contractions of rat aortic rings exposed to 100 mM KCl depolarizing solution
Compound Concentration
(μg/mL)
% Residual
contraction
1 : 1 Mixture of compounds 1
and 2
3 41.0 ± 6.1 (4)*
ent-18-Hydroxytrachyloban-
3β-ol (1)
3 84.4 ± 6.1 (9)*
Hydroxylated ent-18-
hydroxyisopimara-7,15-dien-
3β-ol
3 93.9 ± 1.2 (4)*
Marrubenol 3 47.6 ± 3.2 (6)*
Verapamil 0.05
0.5
52.6 ± 6.7 (4)*
15.8 ± 2.7 (4)*
Data (mean values of n determinations ± s. e. m.) are expressed as percentage of the contraction measured in the absence of drug (control). * P < 0.05 versus control.
#

Acknowledgments

The authors are grateful to Professor R. Flammang for HR-EI-MS and to Professor J. Hanuise for the optical rotation measurement. We wish to thank M. C. Crutzen-Fayt and M. Vandenberg-Leonardy for their skilful technical support. This work was supported by a grant from the ”Fond Spécial de Recherche” of the Catholic University of Louvain (Funds no. 921.2003).

#

References

  • 1 Ngadjui B T, Folefoc G G, Keumedjio F, Dongo E, Sondengam B L, Connolly J D. Crotonadiol, a labdane diterpenoid from the stem bark of Croton zambesicus .  Phytochemistry. 1999;  51 171-4
  • 2 Ngadjui B T, Abegaz B M, Keumedjio F, Folefoc G N, Kapche G WF. Diterpenoids from the stem bark of Croton zambesicus .  Phytochemistry. 2002;  60 345-9
  • 3 Block S, Stévigny C, De Pauw-Gillet M C, De Hoffmann E, Llabrès G, Adjakidjé V. et al . ent-Trachyloban-3β-ol, a new cytotoxic diterpene from Croton zambesicus .  Planta Med. 2002;  68 647-9
  • 4 Block S, Baccelli C, Tinant B, Van Meervelt L, Rozenberg R, Habib Jiwan J -L. et al . Diterpenes from the leaves of Croton zambesicus .  Phytochemistry. 2004;  65 1165-71
  • 5 Adjanohoun E J, Adjakidje V, de Souza S. Contribution aux études ethnobotaniques et floristiques en République Populaire du Bénin. Vol 1 Bénin; Agence de cooperation culturelle et technique 1989: p 245
  • 6 El Bardai S, Morel N, Wibo M, Fabre N, Llabrès G, Lyoussi B. et al . The vasorelaxant activity of marrubenol and marrubiin from Marrubium vulgare .  Planta Med. 2003;  69 75-7
  • 7 Midiwo J O, Owuor F AO, Juma B F, Waterman P G. Diterpenes from the leaf exudate of Psiadia punctulata .  Phytochemistry. 1997;  45 117-20
  • 8 Hasan C H, Healey T M, Waterman P G. 7β-Acetoxytrachyloban-18oic acid from the stem bark of Xylopia quintasii .  Phytochemistry. 1982;  21 177-9
  • 9 Arnone A, Mondelli R, St Pyrek J. 13C NMR spectroscopy of natural substances, IV - 13C NMR studies of trachylobane diterpenes: complete carbon assignment.  Org Magn Res. 1979;  12 429-31
  • 10 Leong Y W, Harrison L J. ent-Trachylobane diterpenoids from the liverwort Mastigophora diclados .  Phytochemistry. 1997;  45 1457-9
  • 11 Spek A. PLATON, Molecular Geometry Program. University of Utrecht The Netherlands; 1998
  • 12 Sheldrick G M. SHELXS-97 and SHELXL-97 Program for the Solution and Refinement of Crystal Structures. University of Göttingen Germany; 1997
  • 13 Kalman A, Argay G, Zivanov-Stakic D, Vladimorov S, Ribar B. Novel observations on the ”Main-Part” isostructuralism exhibited by various steroid molecules: structures of 5-androstene-3β,17β-diol monohydrate and a 1 : 2 adduct ad digitoxigenin and digirezigenin.  Acta Crystallogr. 1992;  B48 812-9
  • 14 Tan E S, Tham F S, Okamura W H. Vitamin D1. Chem Commun 2000: 2345-6
  • 15 El Bardai S, Wibo M, Hamaide-Wibo M C, Lyoussi B, Quetin-Leclerq J, Morel N. Characterisation of marrubenol, a diterpene extracted from Marrubium vulgare, as an L-type calcium channel blocker.  Br J Pharmacol. 2003;  140 1211-6
  • 16 Ohashi K, Bohgaki T, Matsubara T, Shibuya H. Indonesian medicinal plants. XXIII. Chemical structures of two new migrated pimarane-type diterpenes, neoorthosiphols A and B, and suppressive effects on rat thoracic aorta of chemical constituents isolated from the leaves of Ortosiphon aristatus (Lamiaceae).  Chem Pharm Bull. 2000;  48, 3 433-5
  • 17 Ambrosio S R, Tirapelli C R, Bonaventura D, De Oliveira A M, Da Costa F B. Pimarane diterpene from Viguiera arenaria (Asteraceae) inhibit rat carotid contraction.  Fitoterapia. 2002;  73 484-9

Chiara Baccelli

Laboratoire de Pharmacognosie

Unité d’Analyse Chimique et Physico-Chimique des Médicaments

Université Catholique de Louvain

UCL 72.30-CHAM

Av. E. Mounier 72

1200 Bruxelles

Belgium

Phone: +32-(0)276-47230

Fax: +32-(0)276-47253

Email: chiara.baccelli@cham.ucl.ac.be

#

References

  • 1 Ngadjui B T, Folefoc G G, Keumedjio F, Dongo E, Sondengam B L, Connolly J D. Crotonadiol, a labdane diterpenoid from the stem bark of Croton zambesicus .  Phytochemistry. 1999;  51 171-4
  • 2 Ngadjui B T, Abegaz B M, Keumedjio F, Folefoc G N, Kapche G WF. Diterpenoids from the stem bark of Croton zambesicus .  Phytochemistry. 2002;  60 345-9
  • 3 Block S, Stévigny C, De Pauw-Gillet M C, De Hoffmann E, Llabrès G, Adjakidjé V. et al . ent-Trachyloban-3β-ol, a new cytotoxic diterpene from Croton zambesicus .  Planta Med. 2002;  68 647-9
  • 4 Block S, Baccelli C, Tinant B, Van Meervelt L, Rozenberg R, Habib Jiwan J -L. et al . Diterpenes from the leaves of Croton zambesicus .  Phytochemistry. 2004;  65 1165-71
  • 5 Adjanohoun E J, Adjakidje V, de Souza S. Contribution aux études ethnobotaniques et floristiques en République Populaire du Bénin. Vol 1 Bénin; Agence de cooperation culturelle et technique 1989: p 245
  • 6 El Bardai S, Morel N, Wibo M, Fabre N, Llabrès G, Lyoussi B. et al . The vasorelaxant activity of marrubenol and marrubiin from Marrubium vulgare .  Planta Med. 2003;  69 75-7
  • 7 Midiwo J O, Owuor F AO, Juma B F, Waterman P G. Diterpenes from the leaf exudate of Psiadia punctulata .  Phytochemistry. 1997;  45 117-20
  • 8 Hasan C H, Healey T M, Waterman P G. 7β-Acetoxytrachyloban-18oic acid from the stem bark of Xylopia quintasii .  Phytochemistry. 1982;  21 177-9
  • 9 Arnone A, Mondelli R, St Pyrek J. 13C NMR spectroscopy of natural substances, IV - 13C NMR studies of trachylobane diterpenes: complete carbon assignment.  Org Magn Res. 1979;  12 429-31
  • 10 Leong Y W, Harrison L J. ent-Trachylobane diterpenoids from the liverwort Mastigophora diclados .  Phytochemistry. 1997;  45 1457-9
  • 11 Spek A. PLATON, Molecular Geometry Program. University of Utrecht The Netherlands; 1998
  • 12 Sheldrick G M. SHELXS-97 and SHELXL-97 Program for the Solution and Refinement of Crystal Structures. University of Göttingen Germany; 1997
  • 13 Kalman A, Argay G, Zivanov-Stakic D, Vladimorov S, Ribar B. Novel observations on the ”Main-Part” isostructuralism exhibited by various steroid molecules: structures of 5-androstene-3β,17β-diol monohydrate and a 1 : 2 adduct ad digitoxigenin and digirezigenin.  Acta Crystallogr. 1992;  B48 812-9
  • 14 Tan E S, Tham F S, Okamura W H. Vitamin D1. Chem Commun 2000: 2345-6
  • 15 El Bardai S, Wibo M, Hamaide-Wibo M C, Lyoussi B, Quetin-Leclerq J, Morel N. Characterisation of marrubenol, a diterpene extracted from Marrubium vulgare, as an L-type calcium channel blocker.  Br J Pharmacol. 2003;  140 1211-6
  • 16 Ohashi K, Bohgaki T, Matsubara T, Shibuya H. Indonesian medicinal plants. XXIII. Chemical structures of two new migrated pimarane-type diterpenes, neoorthosiphols A and B, and suppressive effects on rat thoracic aorta of chemical constituents isolated from the leaves of Ortosiphon aristatus (Lamiaceae).  Chem Pharm Bull. 2000;  48, 3 433-5
  • 17 Ambrosio S R, Tirapelli C R, Bonaventura D, De Oliveira A M, Da Costa F B. Pimarane diterpene from Viguiera arenaria (Asteraceae) inhibit rat carotid contraction.  Fitoterapia. 2002;  73 484-9

Chiara Baccelli

Laboratoire de Pharmacognosie

Unité d’Analyse Chimique et Physico-Chimique des Médicaments

Université Catholique de Louvain

UCL 72.30-CHAM

Av. E. Mounier 72

1200 Bruxelles

Belgium

Phone: +32-(0)276-47230

Fax: +32-(0)276-47253

Email: chiara.baccelli@cham.ucl.ac.be

Zoom Image

Fig. 1 Structures of ent-18-hydroxytrachyloban-3β-ol (1) and 18-hydroxyisopimara-7,15-dien-3β-ol (2).

Zoom Image

Fig. 2 ORTEP view and atom labelling of ent-18-hydroxytrachyloban-3β-ol and 18-hydroxyisopimara-7,15-dien-3β-ol.